To compare 2 days of antibiotic therapy (AT) to 4 days of AT in neonates with pneumonia and to assess the usefulness of neutrophil values (NV), Creactive protein (CRP), and procalcitonin (PCT) in this population.
INTRODUCTION
Decisions regarding initiation and duration of antibiotic therapy (AT) for respiratory distress in term neonates can be difficult for the clinician and often are based on limited data. Excessive or inadequate duration of AT may result in additional morbidity or mortality. Excessive duration of AT increases the potential for bacterial resistance and nosocomial infection, incurs higher hospital costs, and may interfere with maternal-infant bonding. Inadequate duration of AT may lead to recurrence of symptoms, need for additional testing and therapy, and complications related to persistent infection. When the history suggests the diagnosis of retained lung fluid (e.g., elective Cesarean section delivery, absence of labor, rupture of membranes near delivery, onset of symptoms within 4 hours of birth), the clinician may choose to observe and withhold antibiotic therapy. However, due to the potentially devastating consequences of infection caused by group B streptococcus (GBS) or other pathogens, 1 the clinician is likely to initiate AT in neonates with risk factors for sepsis or persistent respiratory symptoms that begin after 4 to 6 hours following birth, even without a confirmed bacteriologic diagnosis.
Previously, we reported the results of a prospective, randomized trial in which neonates with suspected pneumonia who were treated with ampicillin and gentamicin for 4 days had outcomes similar to those treated with a standard regimen of 7 days. 2 The primary goal of the present study was to determine whether an even shorter course of AT was feasible in selected neonates with suspected pneumonia.
Blood cultures usually are negative in term neonates diagnosed with pneumonia (i.e., signs of respiratory distress and radiographic findings consistent with pneumonia). Since the ''gold standard'' (blood culture) is not generally helpful, other tests have been studied to evaluate their usefulness in guiding clinical decisions. Previous studies have evaluated neutrophil values (NV) and Creactive protein (CRP) in neonates with suspected sepsis and have shown predictive value for these tests when blood cultures are positive. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] Elevation of procalcitonin (PCT) also has been associated with bacterial infection in neonates. 10,11,16 -19 The usefulness of these ancillary studies in term neonates with respiratory distress and suspected pneumonia, but with a negative blood culture, has not been established. Therefore, the secondary goal of this study was to evaluate the additional role of CRP and PCT in these neonates.
MATERIALS AND METHODS
This prospective, randomized study was conducted in the Newborn Nursery (NBN) at Parkland Memorial Hospital (PMH) from January to July 2001. Neonates admitted to the NBN must have a gestational age Z35 weeks by physical examination and birth weight Z2100 g. When chorioamnionitis is diagnosed prior to delivery, asymptomatic neonates receive 48 hours of intramuscular ampicillin 150 mg/kgKday divided every 8 hours and gentamicin 4 mg/kg K day given every 24 hours. All other neonates receive a single dose of intramuscular penicillin G, 60,000 U, within 1 hour of delivery as part of our GBS prophylaxis program. 20 Neonates with symptoms of respiratory distress who do not require cardiorespiratory monitoring or respiratory support are cared for within the NBN. Thus, the study population represented a subset of term neonates with pneumonia who did not warrant continuous monitoring or ventilatory support that is provided in a separate neonatal intensive care unit within our institution.
In an effort to exclude neonates with transient tachypnea of the newborn (TTN) and include only those with suspected pneumonia, we enrolled only neonates whose respiratory symptoms began >6 hours postnatal. Neonates exposed to chorioamnionitis were eligible, provided that respiratory symptoms occurred after 6 hours but before 24 hours postnatal; neonates were not enrolled after 24 hours of ampicillin and gentamicin given for chorioamnionitis exposure since this would increase the duration of AT for study patients and thus detract from the goals of the study. Neonates who were delivered by elective cesarean section in the absence of labor were considered to be at higher risk of TTN, and were excluded. Enrolled neonates were eligible for randomization after 48 hours of AT to either 2 days (AT discontinued) or 4 days of AT if all of the following were present: (a) resolution of respiratory symptoms within 36 hours of initiation of AT and (b) radiographic diagnosis of pneumonia (usually two chest radiographs taken 48 hours apart demonstrating persistent infiltrates inconsistent with retained lung fluid, reviewed by both pediatric attending faculty and a pediatric radiologist) and (c) at least one abnormal NV on complete blood count (CBC) #2 or #3. Following completion of antibiotics, neonates in the 2-and 4-day groups were observed for recurrence of respiratory symptoms in the nursery for 3 days and 1 day, respectively (Figure 1 ). In addition, a follow-up examination was performed 3 to 7 days postdischarge and parents were contacted by telephone approximately 2 weeks postdischarge.
A blood culture and CBC (#1) were obtained by venipuncture at the time of initial evaluation and initiation of AT, and CBCs #2 and #3 were obtained approximately 12 and 24 hours later, respectively. CBCs were analyzed with a Coulter STK-S machine (Beckman Coulter, Inc.; Fullerton, CA), and NV (absolute total neutrophils, ATN; absolute total immature neutrophils, ATI; immature to total neutrophil proportion, I:T) were evaluated using the reference ranges of Manroe et al. 6 For CRP and PCT determinations, blood was obtained by either venipuncture or heelstick at 8 to 12 and 48 hours following initial evaluation. Since these studies are not routinely obtained in our nursery, these times were selected in order to minimize the number of blood samplings, allow for obtaining consent, and avoid delay in initiation of AT. CRP was measured in the clinical laboratory at PMH by nephelometry; a CRP result Z1 mg/dl was considered abnormal. 8 Any remaining serum was frozen at À781C for subsequent measurement of PCT using an immunoluminometric assay (LUMItest PCT, BRAHMS Diagnostica, Berlin, Germany); a PCT result at r48 hours postnatal was considered abnormal if the values fell above the upper limit as described by Chiesa et al. 16 After 48 hours postnatal, a value >1 ng/ml was considered abnormal.
Statistical Analysis
Based on our previous study, 2 we calculated a sample size that would yield a 95% lower confidence bound on the probability of a successful outcome (i.e., adequate treatment of pneumonia). With 40 neonates in each of the two treatment groups, and with no unfavorable outcomes, 95% confidence bounds would exceed the 90% level.
The 2-and 4-day groups were compared using the Student's t-test and the Fisher exact test or w 2 for continuous and categorical variables, respectively. In addition to the comparison of laboratory studies in the 2-and 4-day groups, a secondary analysis was performed in which all 51 study neonates were included. Group assignment (presence or absence of radiographic findings of pneumonia) was made prior to analysis of the results of the laboratory studies. All tests of statistical significance were two-sided, with significance being defined as a<0.05.
This study was approved by the Institutional Review Board at The University of Texas Southwestern Medical Center at Dallas. Informed consent was obtained for all study neonates.
RESULTS
Clinical characteristics of the neonates randomized to the 2-or 4-day groups, as well as those neonates who did not qualify for randomization, are shown in Table 1 ; no statistically significant differences were noted. Three of 14 neonates in the 2-day group developed respiratory distress that recurred after initial symptoms had resolved. In each case, AT was resumed while the neonate was still in the hospital and in the process of completing the observation period according to the study protocol. Details of these three neonates are shown in Table 2 . Although all ATN values were abnormal, no abnormal I:T values were observed for CBCs #1-3. Three of six CRP values and one of six PCT values were abnormal. After recurrence of respiratory symptoms developed in the third A relapse was defined as RR >65/minute on two consecutive determinations during in-hospital observation after AT was discontinued. Symptoms recurred within 14 to 34 hours in the three patients who relapsed in the 2-day group.
Enrolled Study Neonates (n=51)
Criteria for Randomization:
1. Respiratory symptoms resolved ≤ 36 hours after initiation of AT and 2. Pneumonia diagnosed on initial chest x-ray or infiltrates on followup chest x-ray at 48 hours consistent with pneumonia and 3. At least one neutrophil abnormality on either CBC #2 or #3
Randomized n=26 2 days of AT / 3 days of observation* n=14
4 days of AT / 1 day of observation* n=12
Criteria met

Not Randomized n=25
• Persistent tachypnea >36 hours (n=10)
Final radiographic diagnosis not consistent with pneumonia (n=16)
Normal neutrophil values (n=5) (some neonates failed on >1 criterion)
Criteria not met
• • * In-hospital observation (these neonates also were examined 3-7 days post-discharge and parents were contacted by telephone approximately 2 weeks post-discharge) AT, antibiotic therapy CBC, complete blood count Figure 1 . Algorithm describing eligibility of enrolled study neonates for an abbreviated course of AT.
Engle et al. Pneumonia in Term Neonates
neonate, study enrollment was terminated. As shown in Table 3 , no significant differences were noted for neutrophil values, CRP, or PCT between the 2-and 4-day groups.
Results of the secondary analysis comparing laboratory studies in neonates with (n ¼ 35) or without (n ¼ 16) radiographic diagnosis of pneumonia are shown in Table 4 . The most useful tests in differentiating those with radiographic evidence of pneumonia were the initial immature neutrophil values (ATI 1 and I:T 1 ) and initial CRP 1 . An additional analysis of only those neonates with radiographic evidence of pneumonia was performed to determine if duration of respiratory distress could be predicted by CRP 1 or PCT 1 . In this analysis (data available upon request), sensitivity, specificity, and positive and negative predictive values did not exceed 0.80.
DISCUSSION
When treating term neonates with suspected pneumonia, antibiotic therapy is traditionally continued for 7 or more days; [21] [22] [23] however, a shorter course of AT may offer benefits when the neonate readily responds to therapy and symptoms resolve promptly. Our approach has been to continue AT for 7 days; however, our previous study demonstrated that 4 days of AT was comparable to 7 days, provided that patients were selected carefully and appropriate precautions were observed. 2 The present study was intended to determine whether a further reduction in duration of AT was feasible in a selected group of neonates with suspected pneumonia. We observed that the length of AT could not be reduced to 2 days without experiencing a 21% relapse rate, prompting termination of the study. However, the present data provide further confirmation of the efficacy and safety of 4 days of AT for pneumonia in selected term neonates.
This study selected neonates for randomization who met strict criteria, including the resolution of respiratory symptoms within 36 hours of beginning AT. In our experience, some term neonates with pneumonia become asymptomatic within this time frame, and it seemed appropriate to focus on this group when considering candidates for an abbreviated course of AT. The detection of three neonates with pneumonia treated for 2 days of AT who developed recurrence of symptoms emphasizes the importance of a close inhospital observation period as a component of any study that evaluates a shortened duration of AT. We assumed that these neonates had bacterial infections, although a viral cause for their recurrent symptoms is possible. Furthermore, considering the range observed in the onset of initial respiratory symptoms (6 to 54 hours postnatal), this study reinforces the American Academy of Pediatrics recommendation that neonates discharged before 48 hours of age should be examined within 2 to 3 days. 24 Clinicians use clinical, laboratory, and radiographic evidence to make decisions regarding initiation and duration of AT for pneumonia in term neonates. Identification of laboratory tests that improve decision-making in this context would be useful, since blood cultures are rarely positive and interpretation of chest radiographs has some element of subjectivity. 25 CRP and PCT have been evaluated in newborns with a wide range of infections; however, we enrolled only those neonates with suspected pneumonia. The primary value of CRP determinations with suspected neonatal sepsis appears to be the ability of normal values to indicate lack of infection, 3, 4, 8, 13 although failure to mount a CRP response may be a poor prognostic sign in GBS infection. 9, 15 Benitz et al., 8 reported that two CRP levels <1mg/dl indicated lack of infection, but that positive predictive value was low. In the current study, CRP values did not offer additional predictive information above that obtained with neutrophil values regarding either the presence of infiltrates on X-ray or duration of symptoms.
There has been recent interest in the role of PCT in evaluation of neonates for sepsis. Although a number of studies have suggested a potential role for this test, 10, [16] [17] [18] [19] others have not been as positive. 26, 27 To our knowledge, this is the first analysis of PCT values in neonates who were being evaluated exclusively for suspected pneumonia. Similar to our findings regarding CRP values, PCT did not offer additional predictive information above that obtained with NV.
Early termination of this study resulted in a smaller than anticipated sample size. In addition, the use of a single dose of penicillin given to all neonates in our institution as part of a GBS prophylaxis program may limit the ability to generalize our findings. Nevertheless, we are confident in our conclusion that term neonates with pneumonia should receive at least 4 days of AT, even when there is prompt resolution of respiratory distress. It appears that clinical and radiographic findings are most helpful in management of this clinical situation, and that CRP and PCT values have limited additional benefit when NV are available. Further investigations with a larger number of neonates might identify a more useful role for CRP and PCT in this clinical setting. 
